Serum Beta-Carotene and Cancer Risk
Author Information
Author(s): N.J. Wald, S.G. Thompson, J.W. Densem, J. Boreham, A. Bailey
Primary Institution: St Bartholomew's Hospital Medical College
Hypothesis
Is there an inverse association between serum beta-carotene levels and the risk of developing cancer?
Conclusion
The study found that lower serum beta-carotene levels are associated with a higher risk of cancer, particularly lung cancer.
Supporting Evidence
- Men in the top two quintiles of serum beta-carotene had about 60% of the risk of developing cancer compared to those in the bottom quintile.
- The mean beta-carotene level of cancer subjects was significantly lower than that of matched controls.
- The association was strongest for lung cancer.
Takeaway
Men with higher levels of beta-carotene in their blood are less likely to get cancer. It's like having a superhero vitamin that helps keep you safe from getting sick.
Methodology
The study analyzed serum samples from 271 men who developed cancer and 533 matched controls, measuring beta-carotene levels and comparing them.
Potential Biases
There may be bias due to the matching process and the influence of smoking on beta-carotene levels.
Limitations
The study was not large enough to confidently indicate specific cancer sites related to beta-carotene levels.
Participant Demographics
Men aged 35-64 years attending a medical screening center in London.
Statistical Information
P-Value
0.007
Statistical Significance
p=0.007
Want to read the original?
Access the complete publication on the publisher's website